Logo

Genomics-guided tool helps guide immunotherapy choices for advanced kidney cancers

Genomics-guided tool helps guide immunotherapy choices for advanced kidney cancers

A study led by Roswell Park Comprehensive Cancer Center helps explain why a rare and hyper-aggressive subtype of kidney cancer is susceptible to immunotherapy—information that helped researchers create a first-of-its-kind tool to guide treatment decisions for advanced kidney cancers.

👉 Full Story